Skip to content

Patients' Expectations About Effects of Robotic Surgery for Cancer

Patients' Expectations About Effects of Robotic Surgery for Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04844671
Enrollment
3000
Registered
2021-04-14
Start date
2021-04-20
Completion date
2022-06-30
Last updated
2022-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer, Patients' Expectations, Robotic Surgery

Keywords

Patients' Expectations, Robotic surgery, Cancer

Brief summary

Robotic surgery for common surgical procedures is on the rise despite limited evidence to support its clinical benefit. We intend to to map and characterize the prevalence of the patients'expectation that robotic surgery might be superior to open or laparoscopic procedures and to identify the sociodemographic, clinical and organisational factors associated with this expectation.

Detailed description

With the progress of modern medicine, minimally invasive surgical technology has become the main theme in the field of contemporary surgery. As a rising star, the Da Vinci robotic surgery system provides surgeons with a more comprehensive surgical vision, more flexible instrument control, finer anatomy, and more natural comfort compared to open surgery and laparoscopic surgery. However, due to the lack of long-term theoretical basis, the evidence to support its clinical benefits is limited, and its application is limited by related postoperative complications and high operation-related costs. At present, the number of Da Vinci robotic surgery is steadily increasing around the world, but what are the expectations of patients that robotic surgery may be better than open or laparoscopic surgery? It is also unclear what reasons are related to this established expectation. Therefore, we intend to map and characterize the prevalence of the patients' expectation that robotic surgery might be superior to open or laparoscopic procedures and to identify the sociodemographic, clinical and organisational factors associated with this expectation.

Interventions

DEVICEda Vinci Surgical Systems

The da Vinci Surgical Systems enable surgeons to perform delicate and complex operations through a few small incisions with robotic assisted surgery.

Sponsors

First Affiliated Hospital Xi'an Jiaotong University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Clinical diagnosis of Cancer * Have undergone tumor resection with Da Vinci Robotic Surgery System * Volunteer to participate in the study

Exclusion criteria

* Patients with mental illness * Cognitive dysfunction * Cannot complete the questionnaire independently

Design outcomes

Primary

MeasureTime frameDescription
Factors Associated With Patients' Decisions Factors Associated With Patients'Decisions to Choose Robotic Surgery2021.4-2022.4Factors Associated With Patients'Trends in the Adoption of Robotic Surgery for Common Surgical Procedures。According to the relevant regulations of the hospital inpatient satisfaction survey, we have developed a satisfaction rating scale, the evaluation is divided into five grades: very satisfied = 5, relatively satisfied = 4, general = 3, not very satisfied = 2, very dissatisfied = 1, the total score is 1-5.

Secondary

MeasureTime frameDescription
Social demographic characteristics2021.4-2022.4Age, Sex, Education, Occupation
Economic status2021.4-2022.4The ability to pay for medical expenses and the type of medical insurance.Based on the types of medical insurance in China, our survey design is divided into four categories: 1. China new rural cooperative medical system; 2. The medical insurance for urban residents; 3. The medical insurance for urban workers; 4. Commercial insurance. According to China's national income level, our survey design is divided into three stages: personal annual income below 50,000 RMB, 50,000-100,000 RMB, and more than 100,000 RMB.

Countries

China

Contacts

Primary ContactYong Zhang, DR
yongzhang761@mail.xjtu.edu.cn008685324610
Backup ContactRui Jia
jrdoc123@163.com008613576945538

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026